Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Noviral Sweden AB
AB
Active
Org 5591757942
Humlegårdsgatan 4, 114 46
Stockholm
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 2018
1-4 employees
Watchlist
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Noviral Sweden AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
20M
39M
59M
78M
52M
2020
68M
2021
12M
2022
1M
2023
3M
2024
EBITDA
SEK millions
0M
4M
9M
13M
17M
15M
2020
13M
2021
-6M
2022
-6M
2023
-5M
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
52 132
68 263
12 437
829
3 285
Staff expenses
—
—
−2 592
—
—
EBITDA
15 253
12 773
−5 790
−6 298
−4 852
Depreciation & amort.
−0
−0
—
−0
−0
EBIT
15 253
12 773
−5 790
−6 298
−4 852
Net financials
−521
3 629
−361
137
−72
Profit before tax
14 731
13 170
−2 919
−6 161
−4 924
Tax
−3 168
−1 997
—
1 269
−1 269
Net profit
11 563
11 173
−2 919
−4 892
−6 193
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
29 323
28 655
4 804
11 209
11 503
Equity
13 568
11 298
2 379
986
514
Long-term debt
0
0
—
0
9 846
Short-term debt
15 755
14 125
2 425
10 223
1 143
Total debt
15 755
14 125
2 425
10 223
10 989
Financial ratios
5-year trend
EBITDA margin
-147.7%
This company
15.8%
Market median
-1035% vs market
2020
2024
Equity ratio
4.5%
This company
38.2%
Market median
-88% vs market
2020
2024
Return on equity
-1204.9%
This company
18.4%
Market median
-6648% vs market
2020
2024
Net profit margin
-188.5%
This company
8.1%
Market median
-2427% vs market
2020
2024
Asset turnover
0.29×
This company
1.12×
Market median
-74% vs market
2020
2024
Debt / equity
21.38×
This company
0.62×
Market median
-3348% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2019-10-01 – 2020-12-31
View
PDF
More on Noviral Sweden AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
